bf/NYSE:NVO_icon.jpeg

COM:NOVONORDISK

Novo Nordisk A/S

  • Stock

USD

Last Close

102.63

22/11 21:00

Market Cap

628.74B

Beta: -

Volume Today

7.75K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
9.55B
-
10.45B
9.50%
12.06B
15.33%
13.55B
12.37%
14.86B
9.65%
15.85B
6.71%
16.99B
7.15%
18.09B
6.47%
19.08B
5.47%
22.00B
15.34%
28.10B
27.70%
average payables
3.98B
-
4.52B
13.72%
4.94B
9.23%
5.47B
10.74%
5.81B
6.24%
6.18B
6.41%
6.56B
6.05%
6.04B
7.92%
7.29B
20.80%
12.23B
67.66%
20.60B
68.43%
average receivables
14.38B
-
17.09B
18.84%
20.31B
18.84%
22.91B
12.79%
23.87B
4.23%
25.22B
5.64%
28.02B
11.10%
30.67B
9.45%
39.49B
28.77%
52.15B
32.06%
66.38B
27.29%
book value per share
15.89
-
15.37
3.27%
18.27
18.88%
17.89
2.06%
20.14
12.57%
21.42
6.37%
24.26
13.22%
27.13
11.86%
30.80
13.53%
36.85
19.64%
23.77
35.50%
capex per share
-1.36
-
-1.65
21.57%
-2.49
50.71%
-3.27
31.13%
-3.50
7.01%
-5.13
46.68%
-4.73
7.77%
-9.46
100.01%
-3.22
66.01%
-6.51
102.53%
-8.68
33.23%
capex to depreciation
-1.30
-
-1.26
3.06%
-2.16
71.55%
-2.59
19.59%
-2.72
4.97%
-3.16
16.34%
-1.98
37.25%
-3.84
93.46%
-1.23
68.06%
-2.00
63.49%
-4.13
106.20%
capex to operating cash flow
-0.14
-
-0.14
2.62%
-0.17
22.32%
-0.17
2.27%
-0.21
22.77%
-0.28
32.41%
-0.24
13.69%
-0.43
77.05%
-0.13
68.41%
-0.19
39.28%
-0.36
90.97%
capex to revenue
-0.04
-
-0.05
11.95%
-0.06
21.59%
-0.07
24.60%
-0.08
4.69%
-0.11
43.33%
-0.09
17.06%
-0.17
88.98%
-0.05
69.85%
-0.08
58.95%
-0.17
100.87%
cash per share
5.40
-
6.07
12.33%
7.96
31.23%
8.18
2.78%
7.62
6.83%
6.46
15.21%
6.52
0.85%
5.47
16.14%
7.61
39.29%
10.41
36.69%
6.74
35.20%
days of inventory on hand
246.57
-
284.67
15.45%
287.66
1.05%
304.63
5.90%
318.24
4.47%
338.46
6.35%
320.54
5.30%
323.22
0.84%
302.72
6.34%
312.91
3.37%
324.65
3.75%
days payables outstanding
105.63
-
124.07
17.46%
111.09
10.46%
127.69
14.94%
116.13
9.05%
139.98
20.53%
115.53
17.47%
99.69
13.71%
136.85
37.27%
199.99
46.14%
261.32
30.67%
days sales outstanding
66.27
-
78.10
17.84%
73.09
6.41%
79.01
8.10%
76.96
2.60%
87.76
14.04%
87.20
0.64%
92.54
6.12%
121.32
31.10%
118.61
2.23%
118.27
0.29%
debt to assets
0.00
-
0.01
205.66%
0.01
25.10%
0.00
79.91%
0.02
604.93%
0.00
71.91%
0.04
667.62%
0.07
100.23%
0.14
91.70%
0.11
21.98%
0.09
19.65%
debt to equity
0.01
-
0.02
253.79%
0.02
27.85%
0.01
77.86%
0.03
572.23%
0.01
70.79%
0.08
683.52%
0.16
110.10%
0.38
130.30%
0.31
18.00%
0.25
17.94%
dividend yield
0.02
-
0.02
3.41%
0.01
27.48%
0.04
194.97%
0.02
39.30%
0.03
15.44%
0.02
19.12%
0.02
3.65%
0.01
37.58%
0.01
6.72%
0.01
14.60%
earnings yield
0.05
-
0.04
16.84%
0.03
12.23%
0.06
73.79%
0.05
22.82%
0.05
15.69%
0.04
19.96%
0.04
0.54%
0.03
33.84%
0.03
7.78%
0.03
2.52%
enterprise value
526.73B
-
665.68B
26.38%
1.00T
50.68%
619.36B
38.25%
813.73B
31.38%
712.44B
12.45%
905.58B
27.11%
983.83B
8.64%
1.71T
73.34%
2.14T
25.66%
3.14T
46.70%
enterprise value over ebitda
15.02
-
17.47
16.32%
19.11
9.36%
12.00
37.21%
15.60
30.00%
13.92
10.74%
15.67
12.53%
16.34
4.27%
25.24
54.51%
26.12
3.48%
27.84
6.56%
ev to operating cash flow
20.30
-
21.00
3.45%
26.20
24.72%
12.82
51.07%
19.77
54.19%
15.97
19.21%
19.36
21.22%
18.94
2.17%
31.01
63.73%
27.17
12.39%
28.87
6.26%
ev to sales
6.30
-
7.50
18.93%
9.29
23.98%
5.54
40.38%
7.29
31.48%
6.37
12.55%
7.42
16.49%
7.75
4.43%
12.11
56.29%
12.11
0.01%
13.54
11.77%
free cash flow per share
8.32
-
10.43
25.38%
12.40
18.85%
15.83
27.64%
13.15
16.93%
13.31
1.23%
14.97
12.49%
12.80
14.53%
20.73
62.00%
28.31
36.55%
15.62
44.84%
free cash flow yield
0.04
-
0.04
2.98%
0.03
22.30%
0.06
100.66%
0.04
37.66%
0.04
13.10%
0.04
12.38%
0.03
21.91%
0.03
6.95%
0.03
6.84%
0.02
25.74%
graham net net
1.07
-
-0.36
133.39%
-0.69
94.01%
-2.47
257.70%
-3.37
36.41%
-6.18
83.36%
-9.21
48.94%
-15.18
64.90%
-26.72
76.00%
-34.82
30.30%
-23.50
32.51%
graham number
57.97
-
59.10
1.95%
74.66
26.34%
77.69
4.05%
83.59
7.60%
87.73
4.95%
94.62
7.86%
104.99
10.95%
120.05
14.35%
142.57
18.75%
99.92
29.91%
income quality
1.03
-
1.20
16.18%
1.10
8.23%
1.27
15.99%
1.08
15.25%
1.16
6.98%
1.20
3.99%
1.23
2.65%
1.15
6.59%
1.42
23.36%
1.30
8.40%
intangibles to total assets
0.02
-
0.02
22.12%
0.02
31.46%
0.03
18.36%
0.03
16.75%
0.05
42.98%
0.05
0.01%
0.14
206.85%
0.22
55.71%
0.21
3.98%
0.19
9.87%
interest coverage
572.60
-
61.26
89.30%
8.18
86.65%
745.11
9,011.16%
544.08
26.98%
555.86
2.17%
238.56
57.08%
138.78
41.82%
23.93
82.76%
197.91
727.15%
189.25
4.37%
interest debt per share
0.10
-
0.49
385.60%
2.77
465.90%
0.12
95.80%
0.72
520.72%
0.25
65.62%
1.98
698.79%
4.60
132.45%
12.67
175.16%
11.55
8.84%
6.15
46.79%
inventory turnover
1.48
-
1.28
13.38%
1.27
1.04%
1.20
5.57%
1.15
4.28%
1.08
5.98%
1.14
5.59%
1.13
0.83%
1.21
6.77%
1.17
3.26%
1.12
3.62%
invested capital
0.01
-
0.02
253.79%
0.02
27.85%
0.01
77.86%
0.03
572.23%
0.01
70.79%
0.08
683.52%
0.16
110.10%
0.38
130.30%
0.31
18.00%
0.25
17.94%
market cap
537.25B
-
679.35B
26.45%
1.02T
49.98%
637.82B
37.40%
830.89B
30.27%
727.56B
12.44%
916.57B
25.98%
986.23B
7.60%
1.69T
71.31%
2.13T
26.07%
3.13T
47.01%
net current asset value
14.29B
-
9.53B
33.34%
10.31B
8.24%
7.50B
27.29%
7.54B
0.59%
137M
98.18%
-5.56B
4,160.58%
-15.79B
183.80%
-38.17B
141.75%
-49.58B
29.89%
-68.28B
37.72%
net debt to ebitda
-0.30
-
-0.36
19.73%
-0.30
15.89%
-0.36
18.44%
-0.33
8.03%
-0.30
10.14%
-0.19
35.65%
-0.04
79.04%
0.24
691.19%
0.16
32.10%
0.11
30.22%
net income per share
9.40
-
10.10
7.46%
13.56
34.26%
14.99
10.55%
15.42
2.85%
15.96
3.55%
16.41
2.76%
18.05
10.05%
20.79
15.18%
24.51
17.87%
18.67
23.84%
operating cash flow per share
9.68
-
12.09
24.84%
14.89
23.21%
19.10
28.23%
16.65
12.84%
18.44
10.78%
19.70
6.86%
22.26
12.97%
23.95
7.59%
34.82
45.41%
24.29
30.24%
payables turnover
3.46
-
2.94
14.87%
3.29
11.68%
2.86
13.00%
3.14
9.95%
2.61
17.03%
3.16
21.16%
3.66
15.88%
2.67
27.15%
1.83
31.57%
1.40
23.47%
receivables turnover
5.51
-
4.67
15.14%
4.99
6.84%
4.62
7.49%
4.74
2.67%
4.16
12.31%
4.19
0.64%
3.94
5.76%
3.01
23.72%
3.08
2.28%
3.09
0.29%
research and ddevelopement to revenue
0.14
-
0.15
10.38%
0.13
18.64%
0.13
3.33%
0.13
3.70%
0.13
5.52%
0.12
11.97%
0.12
4.52%
0.13
3.63%
0.14
7.66%
0.14
2.79%
return on tangible assets
0.37
-
0.35
4.52%
0.39
11.15%
0.40
2.84%
0.39
3.73%
0.37
5.02%
0.33
11.08%
0.34
4.27%
0.32
6.94%
0.29
7.32%
0.33
12.61%
revenue per share
31.19
-
33.87
8.59%
41.98
23.95%
44.18
5.24%
45.16
2.22%
46.22
2.34%
51.39
11.19%
54.39
5.84%
61.31
12.71%
78.12
27.41%
51.81
33.67%
roe
0.59
-
0.66
11.09%
0.74
12.93%
0.84
12.88%
0.77
8.63%
0.75
2.65%
0.68
9.24%
0.67
1.61%
0.68
1.45%
0.67
1.48%
0.79
18.08%
roic
0.57
-
0.65
14.65%
0.83
26.32%
0.84
2.37%
0.74
11.84%
0.73
1.68%
0.64
12.73%
0.55
13.14%
0.47
15.86%
0.53
13.19%
0.59
11.39%
sales general and administrative to revenue
0.04
-
0.04
5.12%
0.04
10.27%
0.04
0.82%
0.03
4.42%
0.04
3.36%
0.03
6.22%
0.03
5.06%
0.03
7.74%
0.03
12.24%
0.02
17.19%
shareholders equity per share
15.89
-
15.37
3.27%
18.27
18.88%
17.89
2.06%
20.14
12.57%
21.42
6.37%
24.26
13.22%
27.13
11.86%
30.80
13.53%
36.85
19.64%
23.77
35.50%
stock based compensation to revenue
0.00
-
0.00
14.64%
0.00
1.97%
0.00
19.61%
0.00
20.59%
0.00
41.61%
0.00
19.64%
0.01
117.93%
0.01
13.93%
0.01
17.75%
0.01
6.39%
tangible asset value
40.95B
-
38.92B
4.98%
44.81B
15.15%
42.55B
5.03%
46.49B
9.25%
46.69B
0.44%
51.76B
10.85%
42.67B
17.56%
27.57B
35.37%
32.07B
16.30%
46.16B
43.92%
tangible book value per share
15.28
-
14.84
2.89%
17.43
17.44%
16.82
3.50%
18.80
11.75%
19.30
2.66%
21.80
12.96%
18.28
16.14%
12.01
34.32%
14.16
17.91%
10.30
27.27%
working capital
17.83B
-
12.60B
29.32%
14.27B
13.19%
12.33B
13.58%
13.02B
5.63%
4.90B
62.35%
3.47B
29.17%
-4.46B
228.53%
-13.92B
211.85%
-12.75B
8.44%
-30.01B
135.44%

All numbers in USD (except ratios and percentages)